YUNEXI GIRAL: Open Payments
NPI 1811634850 · LAND O LAKES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 54 payments from 16 companies in 2025. Trend: 2023 $1,517 · 2024 $1,375 · 2025 $1,592
Food & beverage: $1,494Education: $98
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $279 |
| Janssen Pharmaceuticals, Inc | 4 | $194 |
| Teva Pharmaceuticals USA, Inc. | 6 | $186 |
| Axsome Therapeutics, Inc. | 6 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $152 |
| Neurocrine BioSciences, Inc. | 3 | $88 |
| Alkermes, Inc. | 4 | $88 |
| Almatica Pharma LLC | 3 | $70 |
| ABBVIE INC. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
Products named: REXULTI, Auvelity, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, LOREEV XR, VRAYLAR.
Industry payments across FL — which companies pay providers there.
